Back to Journals » OncoTargets and Therapy » Volume 11

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Total article views   HTML views PDF downloads Totals
6,975 Dovepress* 6,629+ 752 7,381
PubMed Central* 346 157 503
Totals 6,975 909 7,884
*Since 16 July 2018

View citations on PubMed Central and Google Scholar